丛集性头痛全基因组关联研究揭示遗传易感位点
在荷兰LUCA研究(840例)与NEO对照(1457例)中开展丛集性头痛全基因组关联研究,并在挪威样本(144例/1800对照)中验证。共发现4个全基因组显著独立位点,合计解释7.2%的方差,效应量大于复杂遗传病常见水平,其中3个位点在挪威样本中重复验证。
要点
- 4个独立位点达全基因组显著,合计解释7.2%的丛集性头痛方差。
- rs11579212、rs6541998、rs10184573及rs2499799被识别为风险位点。
- rs11579212、rs10184573及rs2499799代理SNP在挪威样本中重复验证。
核心结论
- 该GWAS识别并重复验证了丛集性头痛的遗传风险位点,效应量大于复杂遗传病常见水平。
研究设计与样本
- 病例对照研究,荷兰LUCA研究840例与NEO未筛选对照1457例,挪威样本144例与HUNT对照1800例用于重复验证。
主要发现
- 4个独立位点(r2 < 0.1)达全基因组显著(p < 5 × 10-8):rs11579212(OR = 1.51,95%CI = 1.33-1.72,近RP11-815 M8.1)、rs6541998(OR = 1.53,95%CI = 1.37-1.74,近MERTK)、rs10184573(OR = 1.43,95%CI = 1.26-1.61,近AC093590.1)、rs2499799(OR = 0.62,95%CI = 0.54-0.73,近UFL1/FHL5),合计解释7.2%的方差。
- rs11579212、rs10184573及rs2499799的代理SNP rs976357(r2 = 1.0)在挪威样本中重复验证(p < 0.05)。
- 基于基因的定位提示ASZ1可能为第五个位点;RNA测序提示POLR1B与TMEM87B在丛集性头痛患者中差异表达。
关键数值与推荐
- 全基因组显著性阈值p < 5 × 10-8,独立位点定义r2 < 0.1。
- 重复验证标准为p < 0.05。
临床怎么用
- 为丛集性头痛的遗传风险评估与机制研究提供候选位点,暂未提示直接临床干预靶点。
局限性
- 重复验证样本量较小(144例),部分位点未在挪威样本中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Identifying common genetic variants that confer genetic risk for cluster headache. METHODS: We conducted a case-control study in the Dutch Leiden University Cluster headache neuro-Analysis program (LUCA) study population (n = 840) and unselected controls from the Netherlands Epidemiology of Obesity Study (NEO; n = 1,457). Replication was performed in a Norwegian sample of 144 cases from the Trondheim Cluster headache sample and 1,800 controls from the Nord-Trøndelag Health Survey (HUNT). Gene set and tissue enrichment analyses, blood cell-derived RNA-sequencing of genes around the risk loci and linkage disequilibrium score regression were part of the downstream analyses. RESULTS: An association was found with cluster headache for 4 independent loci (r2 < 0.1) with genomewide significance (p < 5 × 10-8 ), rs11579212 (odds ratio [OR] = 1.51, 95% confidence interval [CI] = 1.33-1.72 near RP11-815 M8.1), rs6541998 (OR = 1.53, 95% CI = 1.37-1.74 near MERTK), rs10184573 (OR = 1.43, 95% CI = 1.26-1.61 near AC093590.1), and rs2499799 (OR = 0.62, 95% CI = 0.54-0.73 near UFL1/FHL5), collectively explaining 7.2% of the variance of cluster headache. SNPs rs11579212, rs10184573, and rs976357, as proxy SNP for rs2499799 (r2 = 1.0), replicated in the Norwegian sample (p < 0.05). Gene-based mapping yielded ASZ1 as possible fifth locus. RNA-sequencing indicated differential expression of POLR1B and TMEM87B in cluster headache patients. INTERPRETATION: This genomewide association study (GWAS) identified and replicated genetic risk loci for cluster headache with effect sizes larger than those typically seen in complex genetic disorders. ANN NEUROL 2021;90:203-216.
引用
- Harder AVE, Winsvold BS, Noordam R, et al. Genetic Susceptibility Loci in Genomewide Association Study of Cluster Headache. Ann Neurol. 2021. PMID: 34180076. doi:10.1002/ana.26146
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。